Novo Nordisk (alt)
Novo Nordisk (alt)
Share · DK0060534915 · A1XA8R (LSSI)
Overview Financial Indicators
64,40 EUR
0,44 % 0,28 EUR
Lang & Schwarz · Current prices and charts at MoneyPeak
06.06.2025 19:50

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 3,14 % - - -29,51 % -29,51 % 124,89 %

Company Profile for Novo Nordisk (alt) Share

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Invested Funds

The following funds have invested in: Novo Nordisk (alt) invested:

Fund
iShares MSCI Europe Health Care Sector UCITS ETF EUR (Acc)
Vol. in million
4.437,90
Percentage (%)
10,16 %
Fund
iShares Edge MSCI Europe Quality Factor UCITS ETF EUR (Dist)
Vol. in million
250,88
Percentage (%)
5,84 %
Fund
iShares MSCI Europe SRI UCITS ETF USD (Acc)
Vol. in million
1.972,07
Percentage (%)
4,23 %
Fund
iShares MSCI Europe SRI UCITS ETF EUR (Dist)
Vol. in million
29.740,69
Percentage (%)
4,23 %
Fund
iShares MSCI Europe SRI UCITS ETF EUR (Acc)
Vol. in million
156.684,12
Percentage (%)
4,23 %

Company Data

Name Novo Nordisk (alt)
Company Novo Nordisk A/S
Website https://www.novonordisk.com/
Primary Exchange LSSI Lang & Schwarz
WKN A1XA8R
ISIN DK0060534915
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mr. Lars Fruergaard Jorgensen
Market Capitalization 407 Mrd.
Country Denmark
Currency EUR
Employees 59,3 T
Address Novo Alle, Bagsvaerd
IPO Date 2001-06-07

Stock Splits

Date Split
13.09.2023 2:1

Ticker Symbols

Name Symbol
XETRA NOVC.DE

More Shares

Investors who Novo Nordisk (alt) hold also have the following shares in their portfolio:
ALLIANZ AG
ALLIANZ AG Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
BERKSHIRE HATHAWAY INC - CLASS B
BERKSHIRE HATHAWAY INC - CLASS B Share
JOHNSON & JOHNSON
JOHNSON & JOHNSON Share
LBBW IHS 15/25
LBBW IHS 15/25 Bond
LYXOR NASDAQ-100 DAILY (2X) LEVERAGED UCITS ETF - ACC
LYXOR NASDAQ-100 DAILY (2X) LEVERAGED UCITS ETF - ACC ETF
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
Novo Nordisk
Novo Nordisk Share
TESLA INC
TESLA INC Share
TRUE CORP. -NVDR-   BA 4
TRUE CORP. -NVDR- BA 4 Share
UNILEVER PLC
UNILEVER PLC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025